NFKB1 and cancer: Novel delivery systems of phytochemicals in cancer chemotherapy/immunotherapy are also highlighted.<h4>Conclusion</h4>Targeting TLR/NF-κB/NLRP signaling with bioactive phytocompounds reverses chemoresistance and improves the outcome for chemotherapy and immunotherapy in both preclinical and clinical stages.